Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/14/2010US20100260810 Antidepressant dosage form
10/14/2010US20100260809 Preparation For Wound Healing And Prevention Of Bandage Adhesion To The Wound, Containing Chitosan-Glucan
10/14/2010US20100260690 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
10/14/2010US20100260688 New Formulation and Use Thereof
10/14/2010US20100260686 Nanoparticles for brain tumor imaging
10/14/2010US20100260683 Thermolabile liposome with controlled release temperature
10/14/2010US20100260677 Methods and systems for treatment and/or diagnosis
10/14/2010US20100260676 Precision-guided nanoparticle systems for drug delivery
10/14/2010US20100260667 Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease
10/14/2010US20100260007 Preparation of therapeutic foam
10/14/2010DE202010010486U1 Artikel mit wirkstoffhaltigem Venenextrakt Article having an active substance veins extract
10/14/2010DE102009015740A1 Molded mass, where the surface of the molded mass is so provided or modified that an organic material is separated from aqueous saliva and bounded on surface, useful for detecting pathogens, preferably bacteria and viruses in mouth
10/14/2010DE102009015226A1 Template-gestütztes Musterbildungsverfahren von Nanofasern im Electrospinn-Verfahren und deren Anwendungen Template-based pattern formation method of nanofibers in electro spinning method and its applications
10/14/2010CA2761033A1 Method of determining body exit of an ingested capsule
10/14/2010CA2758322A1 Par-1 activation by metalloproteinase-1 (mmp-1)
10/14/2010CA2758260A1 Controlled release devices and methods for delivery of nucleic acids
10/14/2010CA2758258A1 Drug delivery composition
10/14/2010CA2758234A1 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
10/14/2010CA2758100A1 Process for preparing pyrrolidinium salts
10/14/2010CA2757988A1 Active pharmaceutical ingredient adsorbed on solid support
10/14/2010CA2757986A1 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010CA2757979A1 Controlled-release clozapine compositions
10/14/2010CA2757968A1 Use of improved toluidine blue in photodynamic therapy
10/14/2010CA2757961A1 Spray-dried blood products and methods of making same
10/14/2010CA2757752A1 Process for producing rapidly disintegrating spheroids (pellets), granules and/or mixtures thereof
10/14/2010CA2757645A1 Methods and materials for delivering molecules
10/14/2010CA2757310A1 Stable pharmaceutical compositions of diclofenac
10/14/2010CA2756188A1 Methods and apparatus for dispensing medicaments into a punctal plug
10/14/2010CA2756072A1 Polymer-agent conjugates, particles, compositions, and related methods of use
10/14/2010CA2755171A1 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof
10/14/2010CA2750626A1 High dosage doramectin formulation
10/14/2010CA2749354A1 A method for avoiding glass fogging
10/14/2010CA2749253A1 Once-daily oral ir/cr pramipexole formulation
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2239040A1 Use of a gas storage device for storing a pre-defined gas volume and approval of the gas for a medical application
10/13/2010EP2238991A2 Patch and patch preparation
10/13/2010EP2238990A2 Patch and patch preparation
10/13/2010EP2238985A1 High concentration antibody-containing liquid formulation
10/13/2010EP2238981A1 Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser
10/13/2010EP2238980A1 Aqueous compositions containing metronidazole
10/13/2010EP2238979A1 Active pharmaceutical ingredient adsorbed on solid support
10/13/2010EP2238977A2 Skin cleaning products
10/13/2010EP2238976A1 Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
10/13/2010EP2238975A1 Gastric retention controlled drug delivery system
10/13/2010EP2238974A1 Granulate for the formulation of orodispersible tablets
10/13/2010EP2238973A1 Lyophilized preparations of proteasome inhibitors
10/13/2010EP2238972A2 Compound comprising a hydrophobic material and a phospholipid
10/13/2010EP2238251A1 Silencing of polo-like kinase expression using interfering rna
10/13/2010EP2237788A2 Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
10/13/2010EP2237773A1 Method for making patches by electrospray
10/13/2010EP2237772A2 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin
10/13/2010EP2237771A1 Pharmaceutical compositions comprising granules of purified microbial lipase and methods of preventing or treating digestive disorders
10/13/2010EP2237770A2 Biocompatible protein particles, particle devices and methods thereof
10/13/2010EP2237769A2 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals
10/13/2010EP2237768A2 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/13/2010EP2237767A1 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption
10/13/2010EP2237765A1 Lipid vesicles derived from olive oil fatty acids
10/13/2010EP2237757A1 Micro- and/or nano-structured packaging material
10/13/2010EP1246613B1 Osmotic device within an osmotic device
10/13/2010EP1210036B1 Composite shaped bodies and methods for their production and use
10/13/2010CN201603134U 一种新型保健贴 A new health paste
10/13/2010CN1993131B Film-coated tablet
10/13/2010CN1969986B Ganoderma lucidum capsule for improving sleep and immunity, preparation method and use thereof
10/13/2010CN1953768B Highly concentrated liquid formulations of anti-EGFR antibodies
10/13/2010CN1939441B Medicinal composition for treating burn and scald and its preparation
10/13/2010CN1931270B Sobering up and liver protecting Chinese medicine preparation and its preparation process
10/13/2010CN1931258B Preparation process and use of loquat seed extract
10/13/2010CN1927251B Medicament for animals with heat clearing and detoxicating functions and preparing method thereof
10/13/2010CN1927202B Vitamin E nicotinate microcapsule and its preparing process
10/13/2010CN1919207B Gariic and medlar capsule
10/13/2010CN1909916B Effervescent composition including cranberry extract
10/13/2010CN1899375B Chinese medicine preparation for treating protrusion of intervertebral disc
10/13/2010CN1891212B Oral preparation and its preparing method
10/13/2010CN1875979B Soft capsule of hippophae rhamnoides and preparation process thereof
10/13/2010CN1867320B Monodispersed solid lipid particle compositions
10/13/2010CN1819821B Modified-release tablet of bupropion hydrochloride
10/13/2010CN1802171B Stable, aqueous solution of human erythropoietin, not containing serum albumin
10/13/2010CN1799586B Cold treating capsule and its preparation method
10/13/2010CN1795845B Slow release microsphere preparation of derivative of 3,3 - diphenyl propylamine as receptor antagon of toadstool alkali in use for injection
10/13/2010CN1774281B Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
10/13/2010CN1761465B Method for manufacturing coated formulation
10/13/2010CN1754535B Paclitaxel analog microsphere for topical injection, its preparation method and uses
10/13/2010CN1628829B Chinese medicine for treating hypertension, high blood fat and high blood sugar
10/13/2010CN101861154A Vaginal lubricant comprising hyaluronic acid
10/13/2010CN101861148A Lidocaine tape preparation
10/13/2010CN101861146A Pharmaceutical compositions
10/13/2010CN101861145A Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
10/13/2010CN101861144A Lipoic acid pellet composition
10/13/2010CN101861143A Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
10/13/2010CN101861142A Stabilisation of liquid-formulated factor VII(a) polypeptides by aldehyde-containing compounds
10/13/2010CN101861141A Rinse solution
10/13/2010CN101861140A Acid containing lipid formulations
10/13/2010CN101861139A Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
10/13/2010CN101861138A Controlled release azithromycin solid dosages forms
10/13/2010CN101861132A Medical devices having a filter insert for controlled diffusion
10/13/2010CN101857948A Coated particle and manufacturing method thereof
10/13/2010CN101857666A Cellulose ether grafted and modified temperature-sensitive hydrogel and preparation method thereof
10/13/2010CN101857542A Method for manufacturing low-lead granular zinc citrate
10/13/2010CN101856537A Ultrasound mediated mucosal drug delivery system
10/13/2010CN101856500A Application of pharmaceutical excipient
1 ... 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 ... 2991